Molecule Details
InChIKeyIXQHNBONEVULTL-UHFFFAOYSA-N
Canonical SMILESO=C(Nc1c(Cl)c[n+]([O-])cc1Cl)c1ccc(OC(F)F)c2oc3ccncc3c12
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)4
Pfam Stratification Homologous
Avg pChEMBL8.52
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11838
Drug NameRevamilast
CAS Number893555-90-3
Groups investigational
ATC Codes nan
DescriptionRevamilast has been used in trials studying the treatment of Asthma and Rheumatoid Arthritis.

Cross-references: ChemSpider: 28290127 PubChem:11546664 PubChem:347828183
Target Activities (4)
Target Gene Organism Category Pfam pChEMBL Type Source
Q08499 PDE4D Homo sapiens Human PF18100 PF00233 8.5 IC50 ChEMBL
P27815 PDE4A Homo sapiens Human PF18100 PF00233 8.5 IC50 ChEMBL
Q07343 PDE4B Homo sapiens Human PF18100 PF00233 8.5 IC50 ChEMBL;BindingDB
Q08493 PDE4C Homo sapiens Human PF18100 PF00233 8.5 IC50 ChEMBL
DrugBank Target Actions (3)
Target Gene Target Name Action Type
P27815 PDE4A 3',5'-cyclic-AMP phosphodiesterase 4A inhibitor targets
Q07343 PDE4B 3',5'-cyclic-AMP phosphodiesterase 4B inhibitor targets
Q08499 PDE4D 3',5'-cyclic-AMP phosphodiesterase 4D inhibitor targets